Insulin degludec and liraglutide Subcutaneous and NovoSeven RT
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and NovoSeven RT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-NovoSeven RT with MixPro injection
- Insulin degludec and liraglutide Subcutaneous-Novothyrox
- Insulin degludec and liraglutide Subcutaneous-Noxafil
- Insulin degludec and liraglutide Subcutaneous-Noxafil (Posaconazole Delayed-Release Tablets)
- Insulin degludec and liraglutide Subcutaneous-Noxafil (Posaconazole Injection)
- Insulin degludec and liraglutide Subcutaneous-Noxafil (Posaconazole Oral Suspension)
- NovoSeven RT-Insulin degludec Subcutaneous
- NovoSeven RT-Insulin detemir
- NovoSeven RT-Insulin Detemir (Cartridges and Prefilled Syringes)
- NovoSeven RT-Insulin Detemir (Vials)
- NovoSeven RT-Insulin detemir Subcutaneous
- NovoSeven RT-Insulin glargine